These include different forms of phosphorylated tau such as pTau18111–13, pTau21713–18, and pTau23113,19, while other biomarkers such as GFAP20,21, neurofilament light22, and amyloid23 may be useful for detecting AD-related changes up- or downstream of tau accumulation. Here, MAPT is linked to Alzheimer disease.